CRC have an excellent track record in published scientific work:
Magnesium intake and hepatic cancer
Nishizawa Y, Morii H, Durlach J, editors. New Perspectives in Magnesium Research. London: Springer, 2007:155-169
Health needs and the organisation of healthcare
Seminars in the Psychiatry of Learning Disability. London: Gaskell, 2003
The Chain of Survival in South Glamorgan
Commentaries on Health Services 1996. Cardiff: South Glamorgan Health Authority, 1996
Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complications
Diabetic Medicine 2006;23(10):1100
Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster)
Current Medical Research and Opinion 2006;22(1):121
Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK
PharmacoEconomics 2006;24(1):67
Incorporating carer effects into economic evaluation
Pharmacoeconomics 2006;24(1):43-53
The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy
Diabetologia 2006;49(10):2272
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes
Current Medical Research and Opinion 2006;22(8):1523
The impact of the overactive bladder on health-related utility and quality of life
BJU International 2006;97(6):1267
Evaluation of the association between Body Mass Index, waist circumference and health-related utility (EQ5D)
Value in Health 2005;8(6):A76-A77
Evaluation of the association between height and health-related utility (EQ5D(INDEX))
Value in Health 2005;8(3):280-281
Reliable measurement of obesity: Risk of vascular disease complications as a function of body mass index and waist-to-hip ratio
Value in Health 2005;8(3):406-407
Estimation of the financial impact of obesity on the National Health Service and Society in the United Kingdom
Value in Health 2005;8(3):250
Chronic obstructive pulmonary disease: A comparison of estimates of health-related utility (EQ5D) from SF36 data alone, the SF36 plus lung function data, and the SF36 plus the St. George's Respiratory Questionnaire plus lung function data
Value in Health 2005;8(6):A216
The impact of the overactive bladder on quality of life (SF36) and utility (EQ5D)
Value in Health 2005;8(6):A85
Evaluation of the impact on the EQ5D (heath-related utility) of conversion to insulin glargine (lantus) following failure on oral agents in people with type-2 diabetes: Interim analysis
Value in Health 2005;8(3):359
Evaluation of the clinical outcome and financial costs of delaying the onset of frank type-2 diabetes
Value in Health 2005;8(3):355
Evaluation of the cost-effectiveness of Sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom
Clinical Therapeutics 2005;27(11):1834
Evaluation of the association between the EQ-5Dindex (health-related utility) and body mass index (obesity) in hospital-treated people with Type 1 diabetes, Type 2 diabetes and with no diagnosed diabetes
Diabetic Medicine 2005;22(11):1482
Characterisation and comparison of health-related quality of life for patients with renal failure
Current Medical Research and Opinion 2005;21(11):1777
Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes
Current Medical Research and Opinion 2005;21(9):1477
The impact on health-related quality of life (EQ-5D(index)) in people with type 1 diabetes who experience severe hypoglycaemia
Diabetologia 2005;48(Suppl. 1):A292-A293
The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): Descriptive analysis from the first 20,000 subjects
Value in Health 2005;8(5):581
An evaluation of face validity in hospital treated subjects
Value in Health 2005;8(3):379-380
Evaluation of the association between severity of chronic obstructive pulmonary disease (COPD) with health-related utility (EQ5DINDEX) and health care resource use
Value in Health 2005;8(3):326
Diabetic peripheral neuropathy: Evaluation of the association between neuropathic symptoms (NTSS-6-SA) and health-related utility (EQ5D)
Value in Health 2005;8(6):A172-A173
Diabetic peripheral neuropathy: Evaluation of the association between neuropathic symptoms (NTSS-6-SA) and health care resource use and productive losses
Value in Health 2005;8(6):A167
Diabetic peripheral neuropathy: Evaluation of the inter-association between the ranges of neuropathic symptoms
Value in Health 2005;8(6):A154
The association between obesity (BMI) and health-related utility in subjects with Type 1and Type 2 diabetes
Diabetologia 2004;47(Suppl. 1):A345
Total cholesterol, HDL cholesterol and HbA(1c) affect quality-adjusted life years and hospital costs for patients with type 2 diabetes in the United Kingdom - The Cardiff Diabetes Cost Utility Model
Value in Health 2004;7(3):341
Evaluation of improved utility estimates in cost effectiveness analysis of multiple complications in type-2 diabetes
Value in Health 2004;7(6):735
Evaluation of the association between heath-related utility and obesity in hospital-treated subjects
International Journal of Obesity 2004;28(Suppl. 1):S124
Using an artificial neural network to predict utility scores from SF-36 data
Value in Health 2004;7(3):305
Evaluation of the cost-utility of orlistat (Xenical) in the United Kingdom
Value in Health 2004;7(6):721
Including carer utility in economic evaluations: A preliminary analysis of the implications for funding thresholds
Value in Health 2004;7(3):371
Utility values for obesity and preliminary analysis of the Health Outcomes Data Repository
Expert Review of Pharmacoeconomics and Outcomes Research 2004;4(6):657
The epidemiology of hypoglycaemia in a UK population with Type 2 diabetes
Diabetologia 2004;47(Suppl. 1):A84
The impact of vascular events on health-related utility in patients with and without type-2 diabetes
Value in Health 2004;7(6):743
Evaluation of the impact of hypoglycaemia on health care resource use, productivity, fear of hypoglycaemia and health utility in a UK population
Diabetologia 2004;47(Suppl. 1):A323
Evaluation of the association between health-related utility and obesity in hospital treated subjects
Value in Health 2004;7(3):331
Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 2 diabetes in the UK
Curr Med Res Opin. 2007 Feb;23 Suppl 1:21-31
Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK
Curr Med Res Opin. 2007 Feb;23 Suppl 1:7-19
The prescription cost of managing people with type 1 and type 2 diabetes following initiation of treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis
Curr Med Res Opin. 2007 Feb;23 Suppl 1:41-8
The outcome of care in people with type 1 and type 2 diabetes following switching to treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis
Curr Med Res Opin. 2007 Feb;23 Suppl 1:33-9
Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin
Heart 2006;92(2):196
Recent Trends and a Future Forecast of Population Body Mass Index Levels in the United Kingdom
Value in Health 2005;8(3):406
The effects of orlistat in patients with diabetes: Improvement in glycaemic control and weight loss
Current Medical Research and Opinion 2005;21(11):1885
Patterns of graft and patient survival following renal transplantation and evaluation of serum creatinine as a predictor of survival: A review of data collected from one clinical centre over 34 years
Current Medical Research and Opinion 2005;21(11):1793
Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: A record linkage study in a large British population
Heart 2005;91(4):472
Economic analysis of the implementation of autologous transfusion technologies throughout England
International Journal of Technology Assessment in Health Care 2005;21(2):234
The financial costs of hospital care for people with diabetes who have single and multiple macrovascular complications
Diabetes Research and Clinical Practice 2005;67(2):144
Anticoagulation in patients with non-valvular atrial fibrillation: An evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population
Current Medical Research and Opinion 2005;21(12):1905
Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus
American Journal of Hypertension 2005;18(11):1463
Guidelines for computer modeling of diabetes and its complications: Response to American Diabetes Association consensus panel [6] (multiple letters)
Diabetes Care 2005;28(2):500
Evaluating the performance of the Framingham risk equations in a population with diabetes
Diabetic Medicine 2004;21(4):318
Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate.
Diabetes, Obesity and Metabolism 2004;6(4):299
Evaluation of the future supply and demand for blood products in the United Kingdom National Health Service
Transfusion Medicine 2004;14(1):19
Comparative estimates of the financial burden to the UK health system of hospital care for people with and without diabetes in the year before death
Diabetes Research and Clinical Practice 2004;65(3):267
Estimating the health utility of treatment in adults with growth hormone deficiency
Journal of Outcomes Research 2003;7(1-12):1
The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060
Diabetic Medicine 2002;19(SUPPL. 4):1
Estimating the prevalence of diagnosed diabetes in a health district of Wales [1]
Diabetic Medicine 2001;18(5):423
Evaluation of a hospital diabetes specialist nursing service: A randomized controlled trial
Diabetic Medicine 2001;18(4):301
An economic model of the long-term health care burden of Type II diabetes
Diabetologia 2001;44(12):2140
The prevalence of multiple diabetes-related complications
Diabetic Medicine 2000;17(2):146
Estimating the prevalence of diagnosed diabetes in a health district of Wales: The importance of using primary and secondary care sources of ascertainment with adjustment for death and migration
Diabetic Medicine 2000;17(2):141
Relationship between diabetes and mortality: A population study using record linkage
Diabetes Care 2000;23(8):1103
Relative activity and referral patterns for diabetes and non-diabetes in general practice
Diabetic Medicine 2000;17(3):230
Emergency care outside hospital
Hospital medicine (London, England: 1998) 1998;59(3):249
The demand for hospital services for patients with epilepsy
Epilepsia 1998;39(5):537
The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes
Diabetes Care 1998;21(1):42
Ratio of inhaled corticosteroid to bronchodilator as indicator of quality of asthma prescribing (multiple letters) [6]
British Medical Journal 1997;314(7081):680
Hospital utilization as a function of social deprivation: Diabetes vs non-diabetes
Diabetic Medicine 1997;14(7):589
Patterns and costs of hospital care for coronary heart disease related and not related to diabetes
Heart 1997;78(6):544
Epidemiology and costs of acute hospital care for cerebrovascular disease in diabetic and nondiabetic populations
Stroke 1997;28(6):1142
NHS acute sector expenditure for diabetes: The present, future, and excess in-patient cost of care
Diabetic Medicine 1997;14(8):686